GPCR NewsAug 1, 20221 minGPCR Industry NewsTrevena Reports Second Quarter 2022 Results and Provides Business UpdateAugust 2022 "CHESTERBROOK, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq:TRVN), a biopharmaceutical company focused on the...
GPCR NewsApr 1, 20221 minGPCR Industry NewsTrevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare ...April 2022 Trevena Receives up to $40M in OLINVYK ex-US Royalty-Based Financing from R-Bridge Healthcare Fund, an affiliate of CBC Group...
GPCR NewsApr 1, 20221 minGPCR Industry NewsTrevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ...April 2022 Trevena Announces Receipt of First $15 million Tranche in Connection with its $40 million ex-US Royalty-Based Financing with...
GPCR NewsFeb 1, 20221 minGPCR Industry NewsTrevena Announce Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu ...February 2022 Trevena Announces Submission of New Drug Application in China for OLINVYK® by its Partner Jiangsu Nhwa Pharmaceutical...
GPCR NewsDec 1, 20211 minGPCR Industry NewsTrevena Announces Advancement of TRV045 Into Clinical Development for Diabetic Neuropathic PainDecember 2021 "3-part randomized, double-blind, placebo-controlled Phase 1 study will evaluate TRV045 safety, tolerability, and PK in...
GPCR NewsNov 1, 20211 minGPCR Industry NewsTrevena Adds Seasoned Biopharma Commercial Executive to Senior Leadership Team November 2021 "November 11, 2021 7:00am EST Patricia Drake appointed new Chief Commercial Officer CHESTERBROOK, Pa., Nov. 11, 2021 --...